BriaCell Therapeutics Corp. (BCTX)
4.35
+0.06
(+1.40%)
USD |
NASDAQ |
Jan 20, 16:00
4.33
-0.02
(-0.46%)
After-Hours: 20:00
BriaCell Therapeutics EPS Diluted (Quarterly): -4.351 for Oct. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pharmagreen Biotech, Inc. | 0.0001 |
| Venus Concept, Inc. | -12.14 |
| Achieve Life Sciences, Inc. | -0.2831 |
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.278M |
| Total Expenses (Quarterly) | 8.198M |
| Enterprise Value | -3.274M |
| Earnings Yield | -1.11K% |
| Normalized Earnings Yield | -1171.25 |